CRISPR Therapeutics (NASDAQ:CRSP) received an upgrade in its stock rating by analysts at TD Cowen, changing from Sell to Hold, while maintaining a price target of $35.00. The revision in the rating ...

TD Cowen reiterated its Buy rating on Apollo Global Management (NYSE:APO) shares, maintaining a price target of $214.00.

Cowen challenged students to rethink the intersection of society and artificial intelligence at a Yale Political Union debate ...

The widely followed cryptocurrency analyst Benjamin Cowen is warning that Ethereum (ETH) could slide further against Bitcoin ...

Last week was another busy week for the White House, with several notable Executive Orders and more agency leadership changes ...

President Donald Trump appointed William Cowan as acting general counsel of the National Labor Relations Board Monday evening ...

TD Cowen initiated coverage of Repligen (RGEN) with a Buy rating and $200 price target Repligen is well positioned for “industry-leading” ...

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

The analysts say a bundle is a better model for traditional TV giants like WBD, Disney, and Paramount. Netflix is another ...

TD Cowen analyst Jared Levine raised the firm’s price target on Paylocity (PCTY) to $242 from $228 and keeps a Buy rating on the shares. The ...